Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Alzheimer's Disease

Free Subscription 04.03.2019 1 Alzheimers Dement 1 BMC Geriatr 4 Curr Alzheimer Res 10 J Alzheimers Dis 2 J Biol Chem 5 J Neurochem 1 Lancet Neurol 1 Nature 5 Neurobiol Aging 1 Neurochem Res 1 Neurology 2 Neuroreport 2 Neurosci Lett 1 Neuroscience

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Alzheimers Dement

1. ZHANG F, Zhong R, Li S, Fu Z, et al
   Alteration in sleep architecture and electroencephalogram as an early sign of Alzheimer's disease preceding the disease pathology and cognitive decline.
   Alzheimers Dement. 2019 Feb 25. pii: S1552-5260(18)33621.
   PubMed     Text format     Abstract available
   
   

   
   BMC Geriatr

2. WEI M, Shi J, Ni J, Zhang X, et al
   A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population.
   BMC Geriatr. 2019;19:59.
   PubMed     Text format     Abstract available
   
   

   
   Curr Alzheimer Res

3. ROZPEDEK W, Pytel D, Poplawski T, Walczak A, et al
   Inhibition of the PERK-dependent Unfolded Protein Response signaling pathway involved in the pathogenesis of Alzheimer's disease.
   Curr Alzheimer Res. 2019 Feb 28. pii: CAR-EPUB-96942.
   PubMed     Text format     Abstract available
   
   
4. VEZENKOV LT, Tsekova DS, Kostadinova I, Mihaylova R, et al
   Synthesis of New Galanthamine-Peptide Derivatives Designed for Prevention and Treatment of Alzheimer's Disease.
   Curr Alzheimer Res. 2019 Feb 28. pii: CAR-EPUB-96947.
   PubMed     Text format     Abstract available
   
   
5. MEZEIOVA E, Chalupova K, Nepovimova E, Gorecki L, et al
   Donepezil Derivatives Targeting Amyloid-beta cascade in Alzheimer's Disease.
   Curr Alzheimer Res. 2019 Feb 28. pii: CAR-EPUB-96945.
   PubMed     Text format     Abstract available
   
   
6. KANIAKOVA M, Nepovimova E, Kleteckova L, Skrenkova K, et al
   Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
   Curr Alzheimer Res. 2019 Feb 28. pii: CAR-EPUB-96943.
   PubMed     Text format     Abstract available
   
   

   
   J Alzheimers Dis

7. MARKSTEINER J, Oberacher H, Humpel C
   Acyl-Alkyl-Phosphatidlycholines are Decreased in Saliva of Patients with Alzheimer's Disease as Identified by Targeted Metabolomics.
   J Alzheimers Dis. 2019 Feb 21. pii: JAD181278. doi: 10.3233/JAD-181278.
   PubMed     Text format     Abstract available
   
   
8. AMEEN-ALI KE, Simpson JE, Wharton SB, Heath PR, et al
   The Time Course of Recognition Memory Impairment and Glial Pathology in the hAPP-J20 Mouse Model of Alzheimer's Disease.
   J Alzheimers Dis. 2019 Feb 19. pii: JAD181238. doi: 10.3233/JAD-181238.
   PubMed     Text format     Abstract available
   
   
9. ASHFORD JW
   The Dichotomy of Alzheimer's Disease Pathology: Amyloid-beta and Tau.
   J Alzheimers Dis. 2019 Feb 19. pii: JAD181198. doi: 10.3233/JAD-181198.
   PubMed     Text format     Abstract available
   
   
10. TIIMAN A, Jelic V, Jarvet J, Jaremo P, et al
    Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis.
    J Alzheimers Dis. 2019 Feb 21. pii: JAD181144. doi: 10.3233/JAD-181144.
    PubMed     Text format     Abstract available
    
    
11. SHEN L, Ji HF
    Associations Between Gut Microbiota and Alzheimer's Disease: Current Evidences and Future Therapeutic and Diagnostic Perspectives.
    J Alzheimers Dis. 2019 Feb 19. pii: JAD181143. doi: 10.3233/JAD-181143.
    PubMed     Text format     Abstract available
    
    
12. HAMPEL H, Vergallo A, Perry G, Lista S, et al
    The Alzheimer Precision Medicine Initiative.
    J Alzheimers Dis. 2019 Feb 19. pii: JAD181121. doi: 10.3233/JAD-181121.
    PubMed     Text format     Abstract available
    
    
13. SATO K, Mano T, Ihara R, Suzuki K, et al
    Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2019 Feb 22. pii: JAD181115. doi: 10.3233/JAD-181115.
    PubMed     Text format     Abstract available
    
    
14. LIU J, Wang Q, Jing D, Gao R, et al
    Diagnostic Approach of Early-Onset Dementia with Negative Family History: Implications from Two Cases of Early-Onset Alzheimer's Disease with De Novo PSEN1 Mutation.
    J Alzheimers Dis. 2019 Feb 21. pii: JAD181108. doi: 10.3233/JAD-181108.
    PubMed     Text format     Abstract available
    
    
15. REGLAND B, McCaddon A
    Alzheimer's Amyloidopathy: An Alternative Aspect.
    J Alzheimers Dis. 2019 Feb 20. pii: JAD181007. doi: 10.3233/JAD-181007.
    PubMed     Text format     Abstract available
    
    
16. MEDORO A, Bartollino S, Mignogna D, Marziliano N, et al
    Proteases Upregulation in Sporadic Alzheimer's Disease Brain.
    J Alzheimers Dis. 2019 Feb 21. pii: JAD181284. doi: 10.3233/JAD-181284.
    PubMed     Text format     Abstract available
    
    

    
    J Biol Chem

17. EMENDATO A, Milordini G, Zacco E, Sicorello A, et al
    Glycation affects fibril formation of Abeta peptides.
    J Biol Chem. 2018;293:13100-13111.
    PubMed     Text format     Abstract available
    
    
18. MICHNO W, Nystrom S, Wehrli P, Lashley T, et al
    Pyroglutamation of amyloid-betax-42 (Abetax-42) followed by Abeta1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    J Biol Chem. 2019 Feb 27. pii: RA118.006604. doi: 10.1074/jbc.RA118.006604.
    PubMed     Text format     Abstract available
    
    

    
    J Neurochem

19. JHA NK, Jha SK, Kar R, Nand P, et al
    Nuclear Factor-Kappa beta as a therapeutic target for Alzheimer's disease.
    J Neurochem. 2019 Feb 25. doi: 10.1111/jnc.14687.
    PubMed     Text format     Abstract available
    
    
20. MARWARHA G, Schommer J, Lund J, Schommer T, et al
    Palmitate-induced C/EBP homologous protein activation leads to NF-kappaB-mediated increase in BACE1 activity and amyloid beta genesis.
    J Neurochem. 2018;144:761-779.
    PubMed     Text format     Abstract available
    
    
21. SAADIPOUR K, Manucat-Tan NB, Lim Y, Keating DJ, et al
    p75 neurotrophin receptor interacts with and promotes BACE1 localization in endosomes aggravating amyloidogenesis.
    J Neurochem. 2018;144:302-317.
    PubMed     Text format     Abstract available
    
    
22. BAZZIGALUPPI P, Beckett TL, Koletar MM, Lai AY, et al
    Early-stage attenuation of phase-amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of Alzheimer's disease.
    J Neurochem. 2018;144:669-679.
    PubMed     Text format     Abstract available
    
    
23. GORELICK PB
    Prevention of cognitive impairment: scientific guidance and windows of opportunity.
    J Neurochem. 2018;144:609-616.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Neurol

24. ARRANZ AM, De Strooper B
    The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications.
    Lancet Neurol. 2019 Feb 19. pii: S1474-4422(18)30490.
    PubMed     Text format     Abstract available
    
    

    
    Nature

25. FALCON B, Zhang W, Murzin AG, Murshudov G, et al
    Structures of filaments from Pick's disease reveal a novel tau protein fold.
    Nature. 2018;561:137-140.
    PubMed     Text format     Abstract available
    
    

    
    Neurobiol Aging

26. BABILONI C, Del Percio C, Pascarelli MT, Lizio R, et al
    Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases.
    Neurobiol Aging. 2019;77:112-127.
    PubMed     Text format     Abstract available
    
    
27. DUKHINOVA M, Veremeyko T, Yung AWY, Kuznetsova IS, et al
    Fresh evidence for major brain gangliosides as a target for the treatment of Alzheimer's disease.
    Neurobiol Aging. 2019;77:128-143.
    PubMed     Text format     Abstract available
    
    
28. MILNE MR, Qian L, Turnbull MT, Kinna G, et al
    Downregulation of SNX27 expression does not exacerbate amyloidogenesis in the APP/PS1 Alzheimer's disease mouse model.
    Neurobiol Aging. 2019;77:144-153.
    PubMed     Text format     Abstract available
    
    
29. WONG TH, Seelaar H, Melhem S, Rozemuller AJM, et al
    Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations.
    Neurobiol Aging. 2019 Jan 29. pii: S0197-4580(19)30029.
    PubMed     Text format     Abstract available
    
    
30. GAO Y, Ren RJ, Zhong ZL, Dammer E, et al
    Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease.
    Neurobiol Aging. 2019;77:154-157.
    PubMed     Text format     Abstract available
    
    

    
    Neurochem Res

31. SIKANYIKA NL, Parkington HC, Smith AI, Kuruppu S, et al
    Powering Amyloid Beta Degrading Enzymes: A Possible Therapy for Alzheimer's Disease.
    Neurochem Res. 2019 Feb 26. pii: 10.1007/s11064-019-02756.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

32. FEMMINELLA GD, Dani M, Wood M, Fan Z, et al
    Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume.
    Neurology. 2019 Feb 22. pii: WNL.0000000000007133.
    PubMed     Text format     Abstract available
    
    

    
    Neuroreport

33. ZHAO N, Zhang X, Song C, Yang Y, et al
    The effects of treadmill exercise on autophagy in hippocampus of APP/PS1 transgenic mice.
    Neuroreport. 2018;29:819-825.
    PubMed     Text format     Abstract available
    
    
34. JIAO C, Gao F, Ou L, Yu J, et al
    Tetrahydroxystilbene glycoside antagonizes beta-amyloid-induced inflammatory injury in microglia cells by regulating PU.1 expression.
    Neuroreport. 2018;29:787-793.
    PubMed     Text format     Abstract available
    
    

    
    Neurosci Lett

35. ELENI G, Erik P, E TC, Kaj B, et al
    A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer s disease.
    Neurosci Lett. 2019 Feb 23. pii: S0304-3940(19)30125.
    PubMed     Text format     Abstract available
    
    
36. FANNI D, Gerosa C, Rais M, Ravarino A, et al
    The role of neuropathological markers in the interpretation of neuropsychiatric disorders: Focus on fetal and perinatal programming.
    Neurosci Lett. 2018;669:75-82.
    PubMed     Text format     Abstract available
    
    

    
    Neuroscience

37. PU Z, Ma S, Wang L, Li M, et al
    Corrigendum to "Amyloid-beta Degradation and Neuroprotection of Dauricine Mediated by Unfolded Protein Response in a Caenorhabditis elegans Model of Alzheimer's Disease" [Neuroscience 392C (2018) 25-37].
    Neuroscience. 2019 Feb 24. pii: S0306-4522(19)30075.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: